Trifluoroethanol

Trifluoroethanol

SCHEMBL2293008

C[C@@H](O)c1c2ccccc2cc2ccccc12.OCC(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HTR2A P28223 1/20 0.35
CYP1A2 P05177 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GLA P06280 1/20 0.34
CYP2C19 P33261 1/20 0.34
PTPN1 P18031 1/20 0.33
TRPM4 Q8TD43 1/20 0.32
LMNA P02545 1/20 0.32
CCNE2 O96020 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7560523 0.86 UGT2B7 (0.47) UGT2B7MEN1KMT2AALDH1A1HPGD
SCHEMBL240650 0.86 UGT2B7 (0.47) UGT2B7MEN1KMT2AALDH1A1HPGD
SCHEMBL7171670 0.76 MEN1 (0.38) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL3075110 0.73 ALDH1A1 (0.39) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL9975511 0.73 ALDH1A1 (0.37) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL2482183 0.73 ALDH1A1 (0.39) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL977301 0.73 ALDH1A1 (0.39) MEN1KMT2AALDH1A1HPGDL3MBTL1
Trifluoroethanol SCHEMBL3954949 0.72 L3MBTL1 (0.46) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL27500071 0.72 CYP1A2 (0.40) UGT2B7MEN1KMT2AALDH1A1HPGD
SCHEMBL8671624 0.71 RECQL (0.41) UGT2B7MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168617-B2 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use XENOPORT, INC. (US) 2012-05-01 US disclosed
US-7994218-B2 Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use XENOPORT, INC. (US) 2011-08-09 US disclosed
US-20090082440-A1 SIMPLE PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XENOPORT, INC. 2009-03-26 US disclosed
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XENOPORT, INC. 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE ADSL, SLC19A1, SLC25A21 UGT2B7 1544/4885MEN1 1102/4885KMT2A 4109/4885
US-20090082440-A1 SIMPLE PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE ADSL, SLC19A1, SLC25A21 UGT2B7 1480/4885MEN1 1005/4885KMT2A 4079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.